Westlake Village, CA, United States of America

Basel Hasan Taha

This inventor holds 17 USPTO granted patents and 5 published patent applications, plus 5 CIPO patents and 8 EPO patents, primarily in Drug Delivery Devices. Top assignees: Amgen Inc., General Electric Company, Ge Precision Healthcare LLC. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Basel Hasan Taha. Retrieved from https://idiyas.com/inventor/basel-hasan-taha

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17 

% Patents Active = 94.1

 

 

Average Co-Inventor Count = 5.4

ph-index = 8

Forward Citations = 163(Granted Patents)


Location History:

  • Simi Valley, CA (US) (2022)
  • Madison, WI (US) (2010 - 2023)
  • Westlake Village, CA (US) (2020 - 2024)

Company Filing History:


Years Active: 2010-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Drug Delivery Device
Vascular Flow Estimation
CT Imaging
Data Processing
Needle Retraction
Manufacture Method
Controllable System
Image Reconstruction
Flow Adapter
Temporal Data Display
17 patents (USPTO):Explore Patents

Title: Basel Hasan Taha: A Pioneer in Drug Delivery Innovations

Introduction

Basel Hasan Taha, an esteemed inventor based in Westlake Village, California, has made significant contributions to the field of drug delivery devices. With a remarkable portfolio of nine patents, his inventions focus on advancing methodologies that enhance patient care by streamlining the administration of medication.

Latest Patents

Among his latest innovations are two noteworthy patents. The first is a wearable drug delivery device, method of manufacture, and method of use that features a container filled with various therapeutic agents, including specific antibodies like PCSK9 and CGRP. This device is equipped with a needle and an insertion mechanism designed to deliver medication directly into a patient, ensuring a sterile fluid pathway through its connector. Additionally, the device may utilize a cannula, which remains in place after the needle is withdrawn, providing continuous delivery of medication.

The second patent is for a controllable drug delivery system and method of use. This innovative system includes a reservoir and a delivery cannula designed for patient use. It integrates sensors and a controller that optimizes the drug delivery process based on real-time data regarding the device’s operational status, enhancing accuracy and ensuring effective treatment.

Career Highlights

Basel Hasan Taha is currently part of Amgen Inc., a leading biotechnology company dedicated to advancing science to improve patient outcomes. His role within the organization has allowed him to focus on the development of cutting-edge technologies that address critical healthcare challenges.

Collaborations

Throughout his career, Basel has collaborated with talented individuals such as Scott Robert Gibson and Adam B McCullough, contributing to a dynamic environment of innovation and expertise. These collaborations have played a crucial role in the advancement of his research and the successful creation of his numerous patents.

Conclusion

In summary, Basel Hasan Taha stands out as a crucial figure in the field of drug delivery innovations. With nine patents to his name, his work has the potential to revolutionize how medications are administered to patients. His commitment to improving healthcare technology continues to inspire and drive advancements within the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…